What is Ashvattha Therapeutics worth?
$310.0Mlast known valuation
Ashvattha Therapeutics last raised $60.2M in its Later Stage VC (Apr 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 37 names
- ·Watchlist + deal alerts for Ashvattha Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2021 | Later Stage VC | $60.2M | ▮ | ▮ |
| May 2019 | Seed Round | $250K | ▮ | ▮ |
| May 2018 | Seed Round | $400K | ▮ | ▮ |
| Feb 2016 | Seed Round | $300K | ▮ | ▮ |
How Ashvattha Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ashvattha Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Ashvattha Therapeutics worth?
- Ashvattha Therapeutics's last known valuation is $310.0M.
- How much has Ashvattha Therapeutics raised?
- Ashvattha Therapeutics has raised $217.2M in total funding across 4 recorded rounds.
- When did Ashvattha Therapeutics last raise?
- Ashvattha Therapeutics last raised in Apr 2021 (Later Stage VC), raising $60.2M.